201 – 210 of 365
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
DPP-4 Inhibitors -- Clinical Data and Clinical Implications.
(
- Contribution to journal › Scientific review
-
Mark
GLP-1-based therapy of type 2 diabetes: GLP-1 mimetics and DPP-IV inhibitors.
(
- Contribution to journal › Article
-
Mark
Två genombrott i behandling av typ 2-diabetes. Både receptoragonist och enzymhämmare har nu nått kliniken.
(
- Contribution to journal › Article
-
Mark
DPP-4 inhibitors.
2007) In Baillière's Best Practice & Research in Clinical Endocrinology & Metabolism 21(4). p.517-533(
- Contribution to journal › Article
-
Mark
Improved metabolic risk markers following two 6-month physical activity programs among socioeconomic marginalized women of native American ancestry in Lima, Peru
(
- Contribution to journal › Article
-
Mark
Role of VIP and PACAP in islet function
(
- Contribution to journal › Article
-
Mark
G-protein-coupled receptors and islet function-Implications for treatment of type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
Omega-3 fatty acids and other PUFAs and weight control
2007)(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Temporal and dietary fat content-dependent islet adaptation to high-fat feeding-induced glucose intolerance in mice.
(
- Contribution to journal › Article
-
Mark
Glucagon-like peptide-1 accelerates the onset of insulin action on glucose disappearance in mice
(
- Contribution to journal › Article